AMGN
Amgen Inc.
- Operating cash flow, 2025
- $10.0B
- YoY, 2025
- −13.3%
- 5-year CAGR
- −1.0%
- 10-year CAGR
- +0.2%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $10.0B | −13.3% |
| 2024 | $11.5B | +35.6% |
| 2023 | $8.5B | −12.9% |
| 2022 | $9.7B | +5.0% |
| 2021 | $9.3B | −11.8% |
| 2020 | $10.5B | +14.7% |
| 2019 | $9.2B | −19.0% |
| 2018 | $11.3B | +1.1% |
| 2017 | $11.2B | +7.9% |
| 2016 | $10.4B | +6.4% |
| 2015 | $9.7B | +8.7% |
| 2014 | $9.0B | +42.3% |
| 2013 | $6.3B | +7.0% |
| 2012 | $5.9B | +14.9% |
| 2011 | $5.1B | −11.5% |
| 2010 | $5.8B | −8.7% |
| 2009 | $6.3B | +5.8% |
| 2008 | $6.0B | +10.9% |
| 2007 | $5.4B | — |